FDA Approves Abecma for Pretreated R/R Multiple Myeloma
The Food and Drug Administration approved Abecma for adults with relapsed or refractory multiple myeloma who have received two or more previous lines of therapy.
Source: curetoday.com
📰 Fda Abecma News
Fda Abecma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Fda Abecma. Real-time updates on events, politics, business and more.